Interplay of biopharmaceutics, biopharmaceutics drug disposition and salivary excretion classification systems

Saudi Pharmaceutical Journal

Volumn 22, Issue 1, 2014, Pages 79-81

  Idkaidek, Nasir M ^a  

^a UNIVERSITY OF PETRA   (Jordan)

Author keywords

BCS; BDDCS; SECS

Indexed keywords

PLASMA PROTEIN;

ARTICLE; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG SOLUBILITY; HUMAN; LIVER METABOLISM; PHARMACEUTICS; PROTEIN BINDING; SALIVATION;

EID: 84892953116     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2013.02.002     Document Type: Article

References (6)

1. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12:413-420.
2. Benet Leslie.Z., Amidon Gordon.L., Barends Dirk.M., et al. The use of BDDCS in classifying the permeability of marketed drugs. Pharm. Res. 2008, 52(3):483-488.
3. Custodio Joseph M., Wu Chi-Yuan, Benet Leslie Z. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv. Drug Deliv. Rev. 2008, 60(6):717-733.
4. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products - general considerations. March 2003. Division of drug information, Center for drug evaluation and research, Food and drug administration, 5600 Fishers Lane Rockville, MD 20857, USA.
5. Idkaidek N., Arafat T. Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system. Mol. Pharm. 2012, 9(8):2358-2363.
6. Wu Chi-Yuan, Benet Leslie Z. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 2005, 22(1):11-23.